Colorectal Cancer Screening in US Seniors Ages 76–84 Years

Journal of Community Health

Volumn 40, Issue 4, 2015, Pages 769-779

  Klabunde, Carrie N ^a   Shapiro, Jean A ^b   Kobrin, Sarah ^a   Nadel, Marion R ^b   Zapka, Jane M ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer screening; Colorectal cancer; Elderly population; Health services research; Primary care

Indexed keywords

AGE; AGED; ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84956877138     PISSN: 00945145     EISSN: 15733610     Source Type: Journal    
DOI: 10.1007/s10900-015-9998-z     Document Type: Article

References (38)

1. Day, L. W., Walter, L. C., & Velayos, F. (2011). Colorectal cancer screening and surveillance in the elderly patient. American Journal of Gastroenterology,106, 1197–1206.
2. US Cancer Statistics Working Group (2010). United States Cancer Statistics: 1999–2007 Incidence and Mortality Web-based Report. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute.
3. Rabeneck, L., El-Serag, H. B., Davila, J. A., & Sandler, R. S. (2003). Outcomes of colorectal cancer in the United States: No change in survival (1986–1997). American Journal of Gastroenterology,98, 471–477.
4. US Census Bureau. (2012). Current population survey: Annual social and economic supplement. http://www.census.gov/population/age/data/2012.html. Accessed 4 December 2014.
5. National Center for Health Statistics. (2010). Centers for Disease Control and Prevention. National Vital Statistics Reports. Deaths: Preliminary Data for 2008, 59 (2). http://www.cdc.gov/nchs/products/nvsr.htm#vol59/. Accessed 4 December 2014.
6. US Preventive Services Task Force. (2008). Screening for colorectal cancer: US preventive services task force recommendation statement. Annals of Internal Medicine,149, 627–637.
7. Levin, B., Lieberman, D. A., McFarland, B., et al. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology,134, 1570–1595.
8. Qaseem, A., Denberg, T. D., Hopkins, R. H., et al. (2012). Screening for colorectal cancer: A guidance statement from the American College of Physicians. Annals of Internal Medicine,156, 378–386.
9. Holden, D. J., Jonas, D. E., Porterfield, D. S., et al. (2010). Systematic review: Enhancing the use and quality of colorectal cancer screening. Annals of Internal Medicine,152, 668–676.
10. Chen, X., White, M. C., Peipins, L. A., & Seeff, L. C. (2008). Increase in screening for colorectal cancer in older Americans: Results from a national survey. Journal of the American Geriatrics Society,56, 1511–1516.
11. Schenck, A. P., Peacock, S. C., Klabunde, C. N., Lapin, P., Coan, J. F., & Brown, M. L. (2009). Trends in colorectal cancer test use in the Medicare population, 1998–2005. American Journal of Preventive Medicine,37, 1–7.
12. Goodwin, J. S., Singh, A., Reddy, N., Riall, T. S., & Kuo, Y. F. (2011). Overuse of screening colonoscopy in the Medicare population. Archives of Internal Medicine,171, 1335–1343.
13. Berkowitz, Z., Hawkins, N. A., Peipins, L. A., White, M. C., & Nadel, M. R. (2008). Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. Journal of the American Geriatrics Society,56, 307–314.
14. Yabroff, K. R., Klabunde, C. N., Yuan, G., et al. (2011). Are physicians’ recommendations for colorectal cancer screening guideline-consistent? Journal of General Internal Medicine,26, 177–184.
15. Zapka, J. M., Klabunde, C. N., Arora, N. K., Yuan, G., Smith, J. L., & Kobrin, S. C. (2011). Physicians’ colorectal cancer screening discussion and recommendation patterns. Cancer Epidemiology Biomarkers & Prevention,20, 509–521.
16. Zapka, J., Klabunde, C. N., Taplin, S., Yuan, G., Ransohoff, D., & Kobrin, S. (2012). Screening colonoscopy in the US: Attitudes and practices of primary care physicians. Journal of General Internal Medicine,9, 1150–1158.
17. Yabroff, K. R., Zapka, J., Klabunde, C. N., et al. (2011). Systems strategies for support cancer screening in US primary care practice. Cancer Epidemiology Biomarkers & Prevention,20, 2471–2479.
18. Shapiro, J. A., Klabunde, C. N., Thompson, T. D., Nadel, M. R., Seeff, L. C., & White, A. (2012). Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiology Biomarkers & Prevention,6, 895–904. doi:10.1158/1055-9965.EPI-12-0192.
19. Klabunde, C. N., Cronin, K. A., Breen, N., Waldron, W. R., Ambs, A. H., & Nadel, M. R. (2011). Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiology Biomarkers & Prevention,20, 1611–1621.
20. Centers for Disease Control and Prevention (CDC). (2012). Cancer Screening—United States 2010. MMWR Morbidity and Mortality Weekly Report,61, 41–45.
21. Centers for Disease Control and Prevention (CDC). (2013). Vital signs: Colorectal cancer screening test use—United States, 2012. MMWR Morbidity and Mortality Weekly Report,62, 881–888.
22. Han, P. K. J., Coates, R. J., Uhler, R. J., & Breen, N. (2006). Decision making in prostate-specific antigen screening: National Health Interview Survey, 2000. American Journal of Preventive Medicine,30, 394–404.
23. Klabunde, C. N., Lanier, D., Nadel, M. R., McLeod, C., Yuan, G., & Vernon, S. W. (2009). Colorectal cancer screening by primary care physicians: Recommendations and practices, 2006–2007. American Journal of Preventive Medicine,37, 8–16.
24. DeBourcy, A. C., Lichtenberger, S., Felton, S., Butterfield, K. T., Ahnen, D. J., & Denberg, T. D. (2007). Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. Journal of General Internal Medicine,23, 169–174.
25. McQueen, A., Bartholomew, L. K., Greisinger, A. J., et al. (2009). Behind closed doors: Physician-patient discussions about colorectal cancer screening. Journal of General Internal Medicine,24, 1228–1235.
26. Hawley, S. T., McQueen, A., Bartholomew, L. K., et al. (2012). Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer,118, 2726–2734.
27. Walsh, J. M., Kim, S. E., Sawaya, G., et al. (2013). Colorectal cancer screening: What do women from diverse ethnic groups want? Journal of General Internal Medicine,28, 239–246.
28. Denberg, T. D., Melhado, T. V., Coombes, J. M., et al. (2005). Predictors of nonadherence to screening colonoscopy. Journal of General Internal Medicine,20, 989–995.
29. Inadomi, J. M., Vijan, S., Janz, N. K., et al. (2012). Adherence to colorectal cancer screening: A randomized trial of competing strategies. Archives of Internal Medicine,173, 575–582.
30. National Cancer Institute. (2014). Surveillance Epidemiology and End Results Program: Cancer Statistics. http://seer.cancer.gov/statfacts/html/colorectal.html. Accessed 4 December 2014.
31. Lin, O. S., Kozarek, R. A., Schembre, D. B., et al. (2006). Screening colonoscopy in very elderly patients: Prevalence of neoplasia and estimated impact on life expectancy. JAMA,295, 2357–2365.
32. Warren, J. L., Klabunde, C. N., Mariotto, A. B., et al. (2009). Adverse events after outpatient colonoscopy in the medicare population. Annals of Internal Medicine,150, 849–857.
33. Gross, C. P., Soulos, P. R., Ross, J. S., et al. (2011). Assessing the impact of screening colonoscopy on mortality in the Medicare population. Journal of General Internal Medicine,26, 1441–1449.
34. Cho, H., Klabunde, C. N., Yabroff, K. R., et al. (2013). Comorbidity-adjusted life expectancy: A new tool to inform recommendations for optimal screening strategies. Annals of Internal Medicine,159, 667–677.
35. Hayanga, A. J., Waljee, A. K., Kaiser, H. E., Chang, D. C., & Morris, A. M. (2009). Racial clustering and access to colorectal surgeons, gastroenterologists, and radiation oncologists by African Americans and Asian Americans in the United States: A county-level data analysis. Archives of Surgery,144, 532–535.
36. Sarfaty, M., & Wender, R. (2007). How to increase colorectal cancer screening rates in practice. CA: A Cancer Journal for Clinicians,57, 354–366.
37. Green, B. B., Wang, C. Y., Anderson, M. L., et al. (2013). An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: A randomized trial. Annals of Internal Medicine,158(5 Pt 1), 301–311.
38. Anhang Price, R., Zapka, J., Edwards, H., & Taplin, S. H. (2010). Organizational factors and the cancer screening process. JNCI Monographs,2010, 38–57.